Equity

ConocoPhillips·Balance Sheet Statement·19 metrics

Breakdown

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Total liabilities and stockholders' equity	$96B	$96.7B	$122.8B	$124.3B	$122.6B	$122.5B	$121.9B	$122.7B
Additional paid-in capital	$61.4B	$61.4B	$77.5B	$77.6B	$77.6B	$77.7B	$77.7B	$77.8B
Treasury Stock, Value	$68B	$69.2B	$71.2B	$72.7B	$73.9B	$75.2B	$76.2B	$77.2B
Retained earnings	$62.3B	$63.5B	$64.9B	$66.7B	$67.7B	$68.5B	$68.9B	$70B
Total stockholders' equity	$49.7B	$49.9B	$64.8B	$65.2B	$65.6B	$64.9B	$64.5B	$64.5B
Accumulated other comprehensive income (loss)	-$6B	-$5.8B	-$6.5B	-$6.4B	-$5.9B	-$6.1B	-$5.9B	-$6B
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$21M	$21M	$23M	$23M	$23M	$23M	$23M	$23M
Shares Outstanding	—	—	$113M	—	—	—	$44M	—
Convertible Preferred Stock Authorized Shares	—	—	500M	—	—	—	500M	—
Convertible Preferred Stock Issued Shares	—	—	0	—	—	—	0	—
Convertible Preferred Stock Outstanding Shares	—	—	0	—	—	—	0	—
Number of Exercisable Options	—	—	$113M	—	—	—	$44M	—
Number of Vested and Expected to Vest Options	—	—	$113M	—	—	—	$44M	—
Preferred Stock Par Value Per Share	—	—	$0.01	—	—	—	$0.01	—
Share-Based Payment Award Options Outstanding - Number	—	—	2.1M	—	—	—	964.7K	—
Share Repurchase Authorization Limit	—	$45B	$65B	—	—	—	—	—
Weighted Average Exercise Price of Exercisable Options	—	—	$43.16	—	—	—	$48.17	—
Weighted Average Exercise Price of Outstanding Options	—	—	$43.16	—	—	—	$48.17	—
Weighted Average Exercise Price of Vested and Expected to Vest Options	—	—	$43.16	—	—	—	$48.17	—